Hilleman Labs achieves successful outcome of Phase I/II Clinical Trial of its Oral Cholera Vaccine Hillchol
12/10/2017
Delivering on its mission to develop affordable vaccines for global health, Hilleman Lab....
Hilleman Labs successfully completes Phase I/II Clinical Trial of its Heat Stable Rotavirus Vaccine (HSRV)
12/10/2017
Making headway towards providing the developing nations an affordable and easy-to-use &l....
Hilleman Laboratories receives Indo-Swedish grant for developing - Oral Cholera Vaccine (OCV)
28/09/2017
Hilleman Laboratories, a joint-venture partnership between MSD and Wellcome Trust, recei....
